DE69112914D1 - Herstellungsverfahren von Mikrokugeln. - Google Patents

Herstellungsverfahren von Mikrokugeln.

Info

Publication number
DE69112914D1
DE69112914D1 DE69112914T DE69112914T DE69112914D1 DE 69112914 D1 DE69112914 D1 DE 69112914D1 DE 69112914 T DE69112914 T DE 69112914T DE 69112914 T DE69112914 T DE 69112914T DE 69112914 D1 DE69112914 D1 DE 69112914D1
Authority
DE
Germany
Prior art keywords
fatty acid
solvent
acid ester
mixed solvent
microspheres
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69112914T
Other languages
English (en)
Other versions
DE69112914T2 (de
Inventor
Ichiro Yamakawa
Ryoichi Machida
Sumio Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP15285090A external-priority patent/JPH0446116A/ja
Priority claimed from JP15284990A external-priority patent/JPH0446115A/ja
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of DE69112914D1 publication Critical patent/DE69112914D1/de
Publication of DE69112914T2 publication Critical patent/DE69112914T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69112914T 1990-06-13 1991-06-12 Herstellungsverfahren von Mikrokugeln. Expired - Fee Related DE69112914T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP15285090A JPH0446116A (ja) 1990-06-13 1990-06-13 マイクロスフィアの製造方法
JP15284990A JPH0446115A (ja) 1990-06-13 1990-06-13 マイクロスフィアの製造法
JP4857991 1991-02-22

Publications (2)

Publication Number Publication Date
DE69112914D1 true DE69112914D1 (de) 1995-10-19
DE69112914T2 DE69112914T2 (de) 1996-04-04

Family

ID=27293336

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69112914T Expired - Fee Related DE69112914T2 (de) 1990-06-13 1991-06-12 Herstellungsverfahren von Mikrokugeln.

Country Status (9)

Country Link
US (1) US5980947A (de)
EP (1) EP0461630B1 (de)
JP (1) JP3116311B2 (de)
AT (1) ATE127686T1 (de)
CA (1) CA2044353A1 (de)
DE (1) DE69112914T2 (de)
DK (1) DK0461630T3 (de)
ES (1) ES2076412T3 (de)
GR (1) GR3017411T3 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2651320B2 (ja) * 1992-07-16 1997-09-10 田辺製薬株式会社 徐放性マイクロスフェア製剤の製造方法
ES2110573T3 (es) * 1992-08-07 1998-02-16 Takeda Chemical Industries Ltd Produccion de microcapsulas de farmacos solubles en agua.
TW333456B (en) 1992-12-07 1998-06-11 Takeda Pharm Ind Co Ltd A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
GB9310030D0 (en) * 1993-05-15 1993-06-30 Scras Dry processed particles and process for the preparation of the same
NZ260909A (en) * 1993-07-05 1995-04-27 Takeda Chemical Industries Ltd Production of sustained release preparation by allowing a water-soluble polypeptide to permeate into a biodegradable matrix in an aqueous solution
ATE268591T1 (de) 1995-06-27 2004-06-15 Takeda Chemical Industries Ltd Verfahren zur herstellung von zubereitungen mit verzögerter freisetzung
DE19545257A1 (de) 1995-11-24 1997-06-19 Schering Ag Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
US6190702B1 (en) 1996-03-28 2001-02-20 Takeda Chemical Industries, Ltd. Sustained-released material prepared by dispersing a lyophilized polypeptide in an oil phase
KR19990065921A (ko) * 1998-01-19 1999-08-16 김충섭 항생제의서방성제제
WO2001080835A1 (fr) * 2000-04-24 2001-11-01 Tanabe Seiyaku Co., Ltd. Procede de production de microspheres
JP2002129057A (ja) * 2000-10-27 2002-05-09 Riken Vitamin Co Ltd 多芯型カロテノイドビーズ
CA2431285A1 (en) * 2000-12-13 2002-06-20 Merckle Gmbh Microparticles with an improved release profile and method for the production thereof
JP2004516263A (ja) 2000-12-21 2004-06-03 ネクター セラピューティクス 疎水性活性剤を含有するマイクロ粒子の製造のための誘発相転移法
WO2002074340A1 (fr) * 2001-03-16 2002-09-26 Takeda Chemical Industries, Ltd. Procede de fabrication d'une preparation a liberation continue
MXPA05002589A (es) * 2002-09-05 2005-09-20 Ambrose Catherine G Microesferas antibioticas para el tratamiento de infecciones y osteomelitis.
US8986737B2 (en) * 2002-09-05 2015-03-24 Wm. Marsh Rice University Antibiotic microspheres for treatment and prevention of osteomyelitis and enhancement of bone regrowth
CN101229098B (zh) * 2002-09-11 2012-02-29 田边三菱制药株式会社 微球的制备方法及相关的装置
JP4547995B2 (ja) 2003-06-03 2010-09-22 参天製薬株式会社 微粒子の製造法
CA2615939A1 (en) * 2005-08-02 2007-02-08 Miv Therapeutics Inc. Microdevices comprising nanocapsules for controlled delivery of drugs and method of manufacturing same
JP2007222807A (ja) * 2006-02-24 2007-09-06 Nisso Engineering Co Ltd 修復型マイクロカプセルの製造方法
BRPI0720582B1 (pt) 2006-12-18 2021-08-24 Takeda Pharmaceutical Company Limited Composição de liberação prolongada, processo para a preparação da mesma, composição farmacêutica, agente profilático ou terapêutico, e, uso de uma substância fisiologicamente ativa
KR101105292B1 (ko) 2009-06-05 2012-01-17 주식회사 리젠 바이오텍 생분해성 고분자 미세입자와 그의 제조방법
JP6339940B2 (ja) 2011-12-20 2018-06-06 ビョーメ バイオサイエンシズ ピーブイティー.リミテッド 真菌感染症の治療用の局所用オイル組成物
JP2014028764A (ja) * 2012-07-31 2014-02-13 Pure Green Kk 水溶性生理活生物質のマイクロスフィアを含有する油脂及びその製造方法
AU2014276460A1 (en) * 2013-06-04 2015-12-24 Vyome Biosciences Pvt. Ltd. Coated particles and compositions comprising same
JP6944033B1 (ja) * 2020-10-05 2021-10-06 ミヨシ油脂株式会社 生分解性樹脂水系分散体とその製造方法、および生分解性樹脂水系分散体を用いた食品包装用紙
CN114656677B (zh) * 2022-02-11 2022-12-16 华南理工大学 一种基于w/o/w型复乳溶剂挥发的木质素多孔微球及其制备方法与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4933105A (en) * 1980-06-13 1990-06-12 Sandoz Pharm. Corp. Process for preparation of microspheres
US4542025A (en) * 1982-07-29 1985-09-17 The Stolle Research And Development Corporation Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
US4671954A (en) * 1983-12-13 1987-06-09 University Of Florida Microspheres for incorporation of therapeutic substances and methods of preparation thereof
ATE61935T1 (de) * 1985-02-07 1991-04-15 Takeda Chemical Industries Ltd Verfahren zur herstellung von mikrokapseln.
JPS6341416A (ja) * 1986-08-08 1988-02-22 Takeda Chem Ind Ltd 鎮痛性ペプチド含有マイクロカプセルの製造法
JPS63122620A (ja) * 1986-11-12 1988-05-26 Sanraku Inc ポリ乳酸マイクロスフエア及びその製造方法
US4954338A (en) * 1987-08-05 1990-09-04 Rohm And Haas Company Microbicidal microemulsion

Also Published As

Publication number Publication date
DE69112914T2 (de) 1996-04-04
JPH0665063A (ja) 1994-03-08
ATE127686T1 (de) 1995-09-15
CA2044353A1 (en) 1991-12-14
EP0461630A2 (de) 1991-12-18
GR3017411T3 (en) 1995-12-31
DK0461630T3 (da) 1995-11-13
EP0461630B1 (de) 1995-09-13
US5980947A (en) 1999-11-09
JP3116311B2 (ja) 2000-12-11
EP0461630A3 (en) 1992-04-01
ES2076412T3 (es) 1995-11-01

Similar Documents

Publication Publication Date Title
DE69112914D1 (de) Herstellungsverfahren von Mikrokugeln.
SE8403487D0 (sv) Farmaceutisk komposition
DE3872382D1 (de) Pharmazeutische zusammensetzungen mit verlaengerter wirkung und verfahren zu ihrer herstellung.
ATE186221T1 (de) Herstellung von mikropartikeln
CA2076010A1 (fr) Microspheres, leur procede de preparation et leur utilisation
DZ1067A1 (fr) Nouvelles préparations pharmaceutiques à emission prolongée.
DK415689A (da) Farmaceutiske midler
ATE68704T1 (de) Gegenueber lichteinfluss stabilisiertes nifedipin- konzentrat und verfahren zu seiner herstellung.
ATE10626T1 (de) N-substituierte omega-(2-oxo-imidazolin-1-yl)alkans[uren, deren salze und ester, verfahren zu deren herstellung und diese aktiven substanzen enthaltende pharmazeutische zubereitungen.
DK585889A (da) Farmaceutisk praeparat
HUP9903855A2 (hu) Orális adagolásra való valproesavat tartalmazó gyógyszerészeti mikrogömbök
JPS54160753A (en) Nail enamel
ATE67406T1 (de) Nicorandil enthaltende zubereitung zum einspritzen.
ATE106887T1 (de) Ester der 10-(1-hydroxy-äthyl)-11-oxo-1- azatricyclo(7.2.0.0(3,8)>undec-2-ene-2- carbonsäure und deren derivate und verfahren zu ihrer herstellung.
JPS5350141A (en) Stabilization of prostaglandin and prostaglandin analogues
AT289752B (de) Verfahren zur Herstellung von neuen 4-Aminomethylbicyclo[2,2,2]octan- bzw. 4-Aminomethylbicyclo[3,2,2]nonan-1-carbonsäuren und deren 2,5-Diketoverbindungen, sowie deren Salzen, Estern und N-Alkanoylverbindungen
KR890005002A (ko) 방수 콘크리이트 제조용 배합제
PT84946A (de) Zusammensetzung fuer transdermale therapeutische systeme von schleifendiuretika und verfahren zu ihrer herstellung
KR900013959A (ko) γ-카르블린 또는 그들의 제약학적으로 허용 가능한 산부가염 및/또는 수화물, 및 그들로 구성되는 제약학적 조성물
JPS51143645A (en) Process for preparation of 3,3-dimethyl- 2-(2,2-dihalo)cyclopropanecar boxylic acid ester
JPS5762238A (en) Preparation of crotonic acid
JPS52102280A (en) 5,7,8-trimethyltocotrienol-nicotinic acid esters and preparation there of
SE8505801L (sv) I,4-dihydropyridin-derivat, deras framstellning och farmaceutiska beredningar innehallande dessa
JPS5325561A (en) Optical active lactam-2-acetic acid esters and their preparation
JPS51151789A (en) Process for the manufacture of film- forming aqueous emulsion

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee